EXECUTIVE ENGAGEMENTS
POOL
1788
Number of executives repeatedly engaged by snail & email outreach
INTERACTIONS
322
Interactions with Platform & by Email
PARTICIPANTS
72
Unique # Participated
VALIDATIONS
16
Responses Validated*
COMPANIES
43
Responses Validated*
* Login for a full stack data experience
DATE
JAN 2022
TABLES
123
PAGES
193
EDITION
7
PRICE
USD 4950
CODE
MCP16613
*Engagement stats are ongoing and dynamic
RESEARCH MODULES
EXECUTIVES
HIGHLIGHTS & REPORT INDEX
Amid the COVID-19 crisis, the global market for Nanoemulsions estimated at US$8.5 Billion in the year 2020, is projected to reach a revised size of US$14.4 Billion by 2027, growing at a CAGR of 7.8% over the analysis period 2020-2027. Topical, one of the segments analyzed in the report, is projected to record a 7.4% CAGR and reach US$3 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Oral segment is readjusted to a revised 8% CAGR for the next 7-year period.
The Nanoemulsions market in the U.S. is estimated at US$2.5 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$2.5 Billion by the year 2027 trailing a CAGR of 7.3% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 7.2% and 6.3% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 6.4% CAGR.
In the global Parenteral segment, USA, Canada, Japan, China and Europe will drive the 9% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$2.1 Billion in the year 2020 will reach a projected size of US$3.8 Billion by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$1.7 Billion by the year 2027.
SELECT PLAYERS
AbbVie, Inc.; Allergan PLC; AstraZeneca PLC; Covaris, Inc.; Fresenius Kabi AG; GlaxoSmithKline PLC; Kaken Pharmaceutical Co., Ltd.; NanoBio Corporation; Novartis International AG; Sanofi SA
SEGMENTS
» Application (Steroids, Anesthetics, NSAIDs, Immunosuppressant, Antiretroviral, Antimicrobials, Vasodilators) » Route of Administration (Topical, Oral, Parenteral, Nasal)
GEOGRAPHIES
» World » United States » Canada » Japan » China » Europe » France » Germany » Italy » United Kingdom » and Rest of Europe » Asia-Pacific » Rest of World
TABLE OF CONTENTS
| I. METHODOLOGY |
| II. EXECUTIVE SUMMARY |
| 1. MARKET OVERVIEW |
| Influencer Market Insights |
| World Market Trajectories |
| Impact of Covid-19 and a Looming Global Recession |
| 2. FOCUS ON SELECT PLAYERS |
| 3. MARKET TRENDS & DRIVERS |
| 4. GLOBAL MARKET PERSPECTIVE |
| World Current & Future Analysis for Nanoemulsions by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| World 7-Year Perspective for Nanoemulsions by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2020 & 2027 |
| World Current & Future Analysis for Topical by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| World 7-Year Perspective for Topical by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027 |
| World Current & Future Analysis for Oral by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| World 7-Year Perspective for Oral by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027 |
| World Current & Future Analysis for Parenteral by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| World 7-Year Perspective for Parenteral by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027 |
| World Current & Future Analysis for Nasal by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| World 7-Year Perspective for Nasal by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027 |
| World Current & Future Analysis for Steroids by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| World 7-Year Perspective for Steroids by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027 |
| World Current & Future Analysis for Anesthetics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| World 7-Year Perspective for Anesthetics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027 |
| World Current & Future Analysis for NSAIDs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| World 7-Year Perspective for NSAIDs by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027 |
| World Current & Future Analysis for Immunosuppressant by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| World 7-Year Perspective for Immunosuppressant by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027 |
| World Current & Future Analysis for Antiretroviral by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| World 7-Year Perspective for Antiretroviral by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027 |
| World Current & Future Analysis for Antimicrobials by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| World 7-Year Perspective for Antimicrobials by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027 |
| World Current & Future Analysis for Vasodilators by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| World 7-Year Perspective for Vasodilators by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027 |
| III. MARKET ANALYSIS |
| UNITED STATES |
| USA Current & Future Analysis for Nanoemulsions by Route Of Administration - Topical, Oral, Parenteral and Nasal - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| USA 7-Year Perspective for Nanoemulsions by Route Of Administration - Percentage Breakdown of Value Sales for Topical, Oral, Parenteral and Nasal for the Years 2020 & 2027 |
| USA Current & Future Analysis for Nanoemulsions by Application - Steroids, Anesthetics, NSAIDs, Immunosuppressant, Antiretroviral, Antimicrobials and Vasodilators - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| USA 7-Year Perspective for Nanoemulsions by Application - Percentage Breakdown of Value Sales for Steroids, Anesthetics, NSAIDs, Immunosuppressant, Antiretroviral, Antimicrobials and Vasodilators for the Years 2020 & 2027 |
| CANADA |
| Canada Current & Future Analysis for Nanoemulsions by Route Of Administration - Topical, Oral, Parenteral and Nasal - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Canada 7-Year Perspective for Nanoemulsions by Route Of Administration - Percentage Breakdown of Value Sales for Topical, Oral, Parenteral and Nasal for the Years 2020 & 2027 |
| Canada Current & Future Analysis for Nanoemulsions by Application - Steroids, Anesthetics, NSAIDs, Immunosuppressant, Antiretroviral, Antimicrobials and Vasodilators - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Canada 7-Year Perspective for Nanoemulsions by Application - Percentage Breakdown of Value Sales for Steroids, Anesthetics, NSAIDs, Immunosuppressant, Antiretroviral, Antimicrobials and Vasodilators for the Years 2020 & 2027 |
| JAPAN |
| Japan Current & Future Analysis for Nanoemulsions by Route Of Administration - Topical, Oral, Parenteral and Nasal - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Japan 7-Year Perspective for Nanoemulsions by Route Of Administration - Percentage Breakdown of Value Sales for Topical, Oral, Parenteral and Nasal for the Years 2020 & 2027 |
| Japan Current & Future Analysis for Nanoemulsions by Application - Steroids, Anesthetics, NSAIDs, Immunosuppressant, Antiretroviral, Antimicrobials and Vasodilators - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Japan 7-Year Perspective for Nanoemulsions by Application - Percentage Breakdown of Value Sales for Steroids, Anesthetics, NSAIDs, Immunosuppressant, Antiretroviral, Antimicrobials and Vasodilators for the Years 2020 & 2027 |
| CHINA |
| China Current & Future Analysis for Nanoemulsions by Route Of Administration - Topical, Oral, Parenteral and Nasal - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| China 7-Year Perspective for Nanoemulsions by Route Of Administration - Percentage Breakdown of Value Sales for Topical, Oral, Parenteral and Nasal for the Years 2020 & 2027 |
| China Current & Future Analysis for Nanoemulsions by Application - Steroids, Anesthetics, NSAIDs, Immunosuppressant, Antiretroviral, Antimicrobials and Vasodilators - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| China 7-Year Perspective for Nanoemulsions by Application - Percentage Breakdown of Value Sales for Steroids, Anesthetics, NSAIDs, Immunosuppressant, Antiretroviral, Antimicrobials and Vasodilators for the Years 2020 & 2027 |
| EUROPE |
| Europe Current & Future Analysis for Nanoemulsions by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| Europe 7-Year Perspective for Nanoemulsions by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2020 & 2027 |
| Europe Current & Future Analysis for Nanoemulsions by Route Of Administration - Topical, Oral, Parenteral and Nasal - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Europe 7-Year Perspective for Nanoemulsions by Route Of Administration - Percentage Breakdown of Value Sales for Topical, Oral, Parenteral and Nasal for the Years 2020 & 2027 |
| Europe Current & Future Analysis for Nanoemulsions by Application - Steroids, Anesthetics, NSAIDs, Immunosuppressant, Antiretroviral, Antimicrobials and Vasodilators - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Europe 7-Year Perspective for Nanoemulsions by Application - Percentage Breakdown of Value Sales for Steroids, Anesthetics, NSAIDs, Immunosuppressant, Antiretroviral, Antimicrobials and Vasodilators for the Years 2020 & 2027 |
| FRANCE |
| France Current & Future Analysis for Nanoemulsions by Route Of Administration - Topical, Oral, Parenteral and Nasal - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| France 7-Year Perspective for Nanoemulsions by Route Of Administration - Percentage Breakdown of Value Sales for Topical, Oral, Parenteral and Nasal for the Years 2020 & 2027 |
| France Current & Future Analysis for Nanoemulsions by Application - Steroids, Anesthetics, NSAIDs, Immunosuppressant, Antiretroviral, Antimicrobials and Vasodilators - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| France 7-Year Perspective for Nanoemulsions by Application - Percentage Breakdown of Value Sales for Steroids, Anesthetics, NSAIDs, Immunosuppressant, Antiretroviral, Antimicrobials and Vasodilators for the Years 2020 & 2027 |
| GERMANY |
| Germany Current & Future Analysis for Nanoemulsions by Route Of Administration - Topical, Oral, Parenteral and Nasal - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Germany 7-Year Perspective for Nanoemulsions by Route Of Administration - Percentage Breakdown of Value Sales for Topical, Oral, Parenteral and Nasal for the Years 2020 & 2027 |
| Germany Current & Future Analysis for Nanoemulsions by Application - Steroids, Anesthetics, NSAIDs, Immunosuppressant, Antiretroviral, Antimicrobials and Vasodilators - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Germany 7-Year Perspective for Nanoemulsions by Application - Percentage Breakdown of Value Sales for Steroids, Anesthetics, NSAIDs, Immunosuppressant, Antiretroviral, Antimicrobials and Vasodilators for the Years 2020 & 2027 |
| ITALY |
| Italy Current & Future Analysis for Nanoemulsions by Route Of Administration - Topical, Oral, Parenteral and Nasal - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Italy 7-Year Perspective for Nanoemulsions by Route Of Administration - Percentage Breakdown of Value Sales for Topical, Oral, Parenteral and Nasal for the Years 2020 & 2027 |
| Italy Current & Future Analysis for Nanoemulsions by Application - Steroids, Anesthetics, NSAIDs, Immunosuppressant, Antiretroviral, Antimicrobials and Vasodilators - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Italy 7-Year Perspective for Nanoemulsions by Application - Percentage Breakdown of Value Sales for Steroids, Anesthetics, NSAIDs, Immunosuppressant, Antiretroviral, Antimicrobials and Vasodilators for the Years 2020 & 2027 |
| UNITED KINGDOM |
| UK Current & Future Analysis for Nanoemulsions by Route Of Administration - Topical, Oral, Parenteral and Nasal - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| UK 7-Year Perspective for Nanoemulsions by Route Of Administration - Percentage Breakdown of Value Sales for Topical, Oral, Parenteral and Nasal for the Years 2020 & 2027 |
| UK Current & Future Analysis for Nanoemulsions by Application - Steroids, Anesthetics, NSAIDs, Immunosuppressant, Antiretroviral, Antimicrobials and Vasodilators - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| UK 7-Year Perspective for Nanoemulsions by Application - Percentage Breakdown of Value Sales for Steroids, Anesthetics, NSAIDs, Immunosuppressant, Antiretroviral, Antimicrobials and Vasodilators for the Years 2020 & 2027 |
| REST OF EUROPE |
| Rest of Europe Current & Future Analysis for Nanoemulsions by Route Of Administration - Topical, Oral, Parenteral and Nasal - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Rest of Europe 7-Year Perspective for Nanoemulsions by Route Of Administration - Percentage Breakdown of Value Sales for Topical, Oral, Parenteral and Nasal for the Years 2020 & 2027 |
| Rest of Europe Current & Future Analysis for Nanoemulsions by Application - Steroids, Anesthetics, NSAIDs, Immunosuppressant, Antiretroviral, Antimicrobials and Vasodilators - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Rest of Europe 7-Year Perspective for Nanoemulsions by Application - Percentage Breakdown of Value Sales for Steroids, Anesthetics, NSAIDs, Immunosuppressant, Antiretroviral, Antimicrobials and Vasodilators for the Years 2020 & 2027 |
| ASIA-PACIFIC |
| Asia-Pacific Current & Future Analysis for Nanoemulsions by Route Of Administration - Topical, Oral, Parenteral and Nasal - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Asia-Pacific 7-Year Perspective for Nanoemulsions by Route Of Administration - Percentage Breakdown of Value Sales for Topical, Oral, Parenteral and Nasal for the Years 2020 & 2027 |
| Asia-Pacific Current & Future Analysis for Nanoemulsions by Application - Steroids, Anesthetics, NSAIDs, Immunosuppressant, Antiretroviral, Antimicrobials and Vasodilators - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Asia-Pacific 7-Year Perspective for Nanoemulsions by Application - Percentage Breakdown of Value Sales for Steroids, Anesthetics, NSAIDs, Immunosuppressant, Antiretroviral, Antimicrobials and Vasodilators for the Years 2020 & 2027 |
| REST OF WORLD |
| Rest of World Current & Future Analysis for Nanoemulsions by Route Of Administration - Topical, Oral, Parenteral and Nasal - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Rest of World 7-Year Perspective for Nanoemulsions by Route Of Administration - Percentage Breakdown of Value Sales for Topical, Oral, Parenteral and Nasal for the Years 2020 & 2027 |
| Rest of World Current & Future Analysis for Nanoemulsions by Application - Steroids, Anesthetics, NSAIDs, Immunosuppressant, Antiretroviral, Antimicrobials and Vasodilators - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Rest of World 7-Year Perspective for Nanoemulsions by Application - Percentage Breakdown of Value Sales for Steroids, Anesthetics, NSAIDs, Immunosuppressant, Antiretroviral, Antimicrobials and Vasodilators for the Years 2020 & 2027 |
| IV. COMPETITION |
| Total Companies Profiled: 43 |
PREVIEW REPORT
Our robust permission-based engagement strategy requires a one-time double opt-in and/or re-consent for all users. We will re-establish consent once a year from date of last use. Both these practices exceed GDPR mandates.
What we store: Primary coordinates such as email, company address and phone. In-house developed influencer rank.
How we store: Encrypted and additionally secured by firewalls.
How we use your data: Only to contact you directly. We never share your coordinates with any individual or entity outside our company for any reason.
Privacy queries: Privacy@StrategyR.com